Researchers from the group T1D Exchange discovered that obese or overweight teenagers with type 1 diabetes may not receive the same health benefits as type 2 diabetics do when taking the antidiabetic drug metformin. The recent study showed that early benefits from taking the drug disappeared later on in the study.